Skip Navigation

Clinical Trials - No Longer Enrolling

Clinical TrialStudy Result Published
Nerve Growth Factor: Gene Therapy Surgical Intervention Trial

Results pending.

Lewy Body Disease


Memory Training in Mild Cognitive Impairment

Results pending

Neuroimaging & Biomarkers Study - ADNI: Normal Aging, Mild Cognitive Impairment & Early Alzheimer's Disease

Over 100 Study publications
http://www.ncbi.nlm.nih.gov/pubmed?term=ADNI

Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R, Cummings J, Raman R, Thal L for the Alzheimer's Disease Cooperative Study Group Neurology. 2007 April 24: 68; 1356-1363


Vitamins to Slow Alzheimer's Disease (Homocysteine Study) (VITAL)High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial


Mild Cognitive Impairment Study Aricept, Vitamin E or PlaceboVitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group, N Engl J Med. 2005 Jun 9; 352(23):2379-88. Epub 2005 Apr 13


DHA, an Omega 3 Fatty Acide, in Slowing the Progression of Alzheimer's DiseaseDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial


RAGE (Receptor for Advanced Glycation Endproducts) Inhibitor StudyPF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease


Racial Disparities in ADL's

Results pending